These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 27870017

  • 1. Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab.
    Chonat S, Chandrakasan S, Kalinyak KA, Ingala D, Gruppo R, Kalfa TA.
    Br J Haematol; 2016 Nov; 175(4):744-747. PubMed ID: 27870017
    [No Abstract] [Full Text] [Related]

  • 2. Long-term remission with eculizumab in atypical haemolytic uraemic syndrome.
    Carter S, Hewitt I, Kausman J.
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():7-10. PubMed ID: 28176479
    [Abstract] [Full Text] [Related]

  • 3. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
    Okumi M, Tanabe K.
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():9-13. PubMed ID: 26988663
    [Abstract] [Full Text] [Related]

  • 4. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.
    Gately R, San A, Kurtkoti J, Parnham A.
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():32-35. PubMed ID: 28176475
    [Abstract] [Full Text] [Related]

  • 5. Effective treatment of chemotherapy induced atypical Haemolytic Uraemic Syndrome: a case series of 7 treated patients.
    Weitz IC, Deloughery T.
    Br J Haematol; 2018 Oct; 183(1):136-139. PubMed ID: 28857126
    [No Abstract] [Full Text] [Related]

  • 6. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N.
    Intern Med J; 2015 Oct; 45(10):1054-65. PubMed ID: 26247170
    [Abstract] [Full Text] [Related]

  • 7. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 8. Postpartum atypical hemolytic uremic syndrome with complement factor H mutation complicated by reversible cerebrovascular constriction syndrome successfully treated with eculizumab.
    Yamaguchi M, Hori M, Hiroshi N, Maruyama S.
    Thromb Res; 2017 Mar; 151():79-81. PubMed ID: 28167400
    [No Abstract] [Full Text] [Related]

  • 9. Irreversible severe kidney injury and anuria in a 3-month-old girl with atypical haemolytic uraemic syndrome under administration of eculizumab.
    Okuda Y, Ishikura K, Terano C, Harada R, Hamada R, Hataya H, Ogata K, Honda M.
    Nephrology (Carlton); 2016 Mar; 21(3):261-5. PubMed ID: 26818219
    [Abstract] [Full Text] [Related]

  • 10. Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis.
    Legendre CM, Campistol JM, Feldkamp T, Remuzzi G, Kincaid JF, Lommelé Å, Wang J, Weekers LE, Sheerin NS.
    Transpl Int; 2017 Dec; 30(12):1275-1283. PubMed ID: 28801959
    [Abstract] [Full Text] [Related]

  • 11. ATYPICAL HEMOLYTIC UREMIC SYNDROME IN AN ADULT SUCCESSFULLY TREATED WITH ECULIZUMAB.
    Chaudoir C, Ong MG, Gu X, Veillon D, Cotelingam J.
    J La State Med Soc; 2016 Dec; 168(1):12-5. PubMed ID: 26986861
    [Abstract] [Full Text] [Related]

  • 12. Subclinical atypical haemolytic uremic syndrome relapse following discontinuation of eculizumab.
    Choo SZ, Brown F.
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():4-6. PubMed ID: 28176471
    [Abstract] [Full Text] [Related]

  • 13. Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab.
    Vakiti A, Singh D, Pilla R, Alhaj-Moustafa M, Fitzpatrick KW.
    J Oncol Pharm Pract; 2019 Jun; 25(4):1011-1015. PubMed ID: 29768958
    [Abstract] [Full Text] [Related]

  • 14. [Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].
    Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K.
    Rinsho Ketsueki; 2018 Jun; 59(2):182-186. PubMed ID: 29515071
    [Abstract] [Full Text] [Related]

  • 15. Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab.
    Servais A, Devillard N, Frémeaux-Bacchi V, Hummel A, Salomon L, Contin-Bordes C, Gomer H, Legendre C, Delmas Y.
    Nephrol Dial Transplant; 2016 Dec; 31(12):2122-2130. PubMed ID: 27587606
    [Abstract] [Full Text] [Related]

  • 16. Thrombotic microangiopathy: eculizumab for atypical haemolytic uraemic syndrome: what next?
    Fakhouri F, Frémeaux-Bacchi V.
    Nat Rev Nephrol; 2013 Sep; 9(9):495-6. PubMed ID: 23917793
    [No Abstract] [Full Text] [Related]

  • 17. [Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].
    Okano M, Matsumoto T, Nakamori Y, Ino K, Miyazaki K, Fujieda A, Sugimoto Y, Tawara I, Yamaguchi M, Ohishi K, Miwa H, Masuya M, Wada H, Katayama N.
    Rinsho Ketsueki; 2018 Sep; 59(2):178-181. PubMed ID: 29515070
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic complement inhibition – from experimental to clinical medicine.
    Lappegård KT, Bjerre A, Tjønnfjord GE, Mollnes TE.
    Tidsskr Nor Laegeforen; 2015 Oct 20; 135(19):1745-9. PubMed ID: 26486669
    [Abstract] [Full Text] [Related]

  • 19. Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab.
    Freyer CW, Bange EM, Skuli S, Hsu M, Lin J, Cuker A, Cohen AD, Garfall A.
    Clin Lymphoma Myeloma Leuk; 2021 Nov 20; 21(11):e845-e849. PubMed ID: 34366267
    [No Abstract] [Full Text] [Related]

  • 20. Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome.
    Wijnsma KL, Duineveld C, Volokhina EB, van den Heuvel LP, van de Kar NCAJ, Wetzels JFM.
    Nephrol Dial Transplant; 2018 Apr 01; 33(4):635-645. PubMed ID: 29106598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.